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We identiﬁed overlapping homozygous regions within the DFNB25 locus in two Dutch and ten Pakistani families with sensorineural
autosomal-recessive nonsyndromic hearing impairment (arNSHI). Only one of the families, W98-053, was not consanguineous, and
its sibship pointed toward a reduced critical region of 0.9 Mb. This region contained the GRXCR1 gene, and the orthologous mouse
gene was described to be mutated in the pirouette (pi) mutant with resulting hearing loss and circling behavior. Sequence analysis of
the GRXCR1 gene in hearing-impaired family members revealed splice-site mutations in two Dutch families and a missense and
nonsense mutation, respectively, in two Pakistani families. The splice-site mutations are predicted to cause frameshifts and premature
stop codons. In family W98-053, this could be conﬁrmed by cDNA analysis. GRXCR1 is predicted to contain a GRX-like domain. GRX
domains are involved in reversible S-glutathionylation of proteins and thereby in the modulation of activity and/or localization of these
proteins. The missense mutation is located in this domain, whereas the nonsense and splice-site mutations may result in complete or
partial absence of the GRX-like domain or of the complete protein. Hearing loss in patients with GRXCR1mutations is congenital and is
moderate to profound. Progression of the hearing loss was observed in family W98-053. Vestibular dysfunction was observed in some
but not all affected individuals. Quantitative analysis of GRXCR1 transcripts in fetal and adult human tissues revealed a preferential
expression of the gene in fetal cochlea, which may explain the nonsyndromic nature of the hearing impairment.Introduction
Autosomal-recessive nonsyndromic hearing impairment
(arNSHI [MIM 220700]) is the most common inherited
sensory disorder in humans, after color blindness, and
exhibits a very high allelic and locus heterogeneity. At
present, about 60 loci are known for arNSHI, and they
are named as ‘‘DFNB’’ followed by an identiﬁcation
number. For about half of these loci, the causal genes are
still unknown. Their identiﬁcation is hampered by the
large size of the critical regions, which are often deﬁned
by linkage analysis and/or homozygosity mapping in
a small number of consanguineous families or even in
a single family. (Hereditary Hearing Loss Homepage).1–3
Critical regions can be signiﬁcantly delimited by a search
for additional consanguineous families with linkage to
the same locus. Alternatively, the method of determining
regions that are identical by descent (IBD) in affected
family members of nonconsanguineous families can be
employed. Because the sizes of IBD regions are inversely
correlated with the number of generations between the
patients and the common ancestors of their parents, anal-
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illustrated by the study of Collin et al. and is further sup-
ported by the results of Hildebrandt et al.4,5
In the present study, we describe the narrowing of the
DFNB25 locus by using homozygosity mapping in consan-
guineous families of Pakistani and Dutch origin and in a
small nonconsanguineous family of Dutch origin. The crit-
ical region contains the GRXCR1 gene, and the ortholo-
gous gene in mouse was previously reported to carry the
causal mutation in the pirouette (pi) mutant, which has
hearing loss and circling behavior (Hunker, K.L. et al.,
2005, Assoc. Res. Otolaryngol., abstract; see also Odeh
et al. in this issue6). GRXCR1 is predicted to have a GRX-
like domain; GRX domains are the catalytic domains in
glutaredoxins and are involved in the reversible S-gluta-
thionylation of proteins and thereby in the modulation
of their activity and/or localization.7 A role in actin organi-
zation in hair cells has been suggested because of the local-
ization of GRXCR1 in the hair bundle and stereocilia
abnormalities in the pi mutant. (Hunker, K.L. et al., 2006,
Assoc. Res. Otolaryngol., abstract).8,9 We demonstrate that
mutations in the GRXCR1 gene are responsible for arNSHI
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Subjects and Methods
Families
Families W98-053 and W07-0122 are of Dutch origin and have
three and one hearing impaired (HI) members, respectively (Fig-
ure S1, available online). The parents in the latter family are ﬁrst
cousins. Consanguineous families DEM 4265 and DEM 4349 are
from Pakistan and have four and two HI pedigree members,
respectively (Figures S2 and S3). For eight additional consanguin-
eous Pakistani families that displayed suggestive linkage to the
DFNB25 locus, no potentially causative GRXCR1 mutations were
identiﬁed: pedigrees DEM 4003A, DEM 4026, DEM 4124A, and
DEM 4335; with six, ﬁve, four, and four HI family members,
respectively, in multiple branches. Pedigrees DEM 4045, DEM
4145, DEM 4171, and DEM 4259 have two, three, two, and two
HI family members, respectively, in a single branch.
Family members were examined by otoscopy and pure-tone
audiometry in a sound-treated room in accordance with current
clinical standards. The patient of family W07-0122 was tested by
standardized free-ﬁeld audiometry. Classiﬁcation of the hearing
loss is in accordance with the GENDEAF guidelines (Hereditary
Hearing Loss Homepage). Vestibular function of HI members of
families W98-053 and W07-0122 was evaluated by analyzing
eye-movement responses to earth-horizontal rotatory stimulation
(eyes open) in the dark as described previously.10 This study was
approved by the local medical ethics committees in The
Netherlands, Pakistan, and the United States. Informed consent
was obtained from all participating subjects or, in the case of
children, from their parents.Homozygosity Mapping and Linkage Analysis
Genomic DNAwas isolated from peripheral-blood lymphocytes by
standard procedures. DNA samples from families W98-053 and
W07-0122 were genotyped by use of the Affymetrix mapping
250K SNP array. Total genomic DNA (250 ng) was digested with
NspI. Generic primers that recognize the adaptor sequence are
used to amplify adaptor-ligated DNA fragments. PCR conditions
were optimized to preferentially amplify fragments in the 200–
1100 bp size range. The ampliﬁed DNA was then fragmented
with the Affymetrix fragmentation reagent, in accordance with
the manufacturer’s protocol, to a size of 50–200 bp and was then
labeled and hybridized to a GeneChip Human Mapping 250K
array. Genotype calling and calculation of the regions of homozy-
gosity was performed with the Genotyping Console software
(Affymetrix), with the default settings used. The families from
Pakistan were genotyped with several platforms. Pedigrees DEM
4265 and DEM 4349 were genotyped with the Illumina linkage
Panels IVb and 12, respectively. Both of these linkage panels
contain ~6000 SNP loci. Of those pedigrees that displayed (sugges-
tive) linkage to DFNB25 but lacked potentially causative GRXCR1
mutations, DEM 4259 and DEM 4345 were genotyped with the
Illumina linkage panels IVb and 12, respectively. For pedigrees
DEM 4003A, DEM 4026, DEM 4045, DEM 4124A, DEM 4145,
and DEM 4171, a genome scan was carried out with the use of
~400 ﬂuorescently labeled, short tandem repeat markers covering
both autosomes and sex chromosomes at a spacing of ~10 cM.
PEDCHECK was used to identify Mendelian inconsistencies, and
the MERLIN program was utilized to detect potential genotyping
errors that did not produce a Mendelian inconsistency.11,12 Two-
point linkage analysis was carried out with the MLINK program
of the FASTLINK computer package, and multipoint linkage anal-The Americaysis was performed with ALLEGRO.13,14 An autosomal-recessive
mode of inheritance with complete penetrance and a disease-allele
frequency of 0.001 were assumed. Marker-allele frequencies were
estimated from the founders, as well as from these founders’
reconstructed genotypes both from these pedigrees and from
additional pedigrees that underwent a genome scan at the same
time. Genetic-map distances were then derived from the Rutgers
combined linkage-physical map of the human genome, either
directly or by interpolation.15 For identiﬁcation of regions of
homozygosity, haplotypes were constructed via SIMWALK2.16,17
Mutation Analysis
Primers for ampliﬁcation of exons and exon-intron boundaries of
GRXCR1 and exon 1 of ATP8A1 (MIM 609542) were designed with
ExonPrimer and the reference sequence NT_006238.10. Primer
sequences and PCR conditions are provided in Table S1. Ampliﬁca-
tion by PCR was performed on 40 ng of genomic DNA with Taq
DNA polymerase (Invitrogen). Because the PCR product of exon
1 of ATP8A1 has a GC content of 72%, dimethyl sulfoxide was
added to the PCR mixture for a ﬁnal concentration of 10%. PCR
fragments were puriﬁed with the use of NucleoFast 96 PCR plates
(Clontech) in accordance with the manufacturer’s protocol.
Sequence analysis was performed with the ABI PRISM Big Dye
Terminator Cycle Sequencing V3.1 Ready Reaction Kit and the ABI
PRISM 3730 DNA Analyzer (Applied Biosystems). NT_006238.10
was used as a reference sequence for both GRXCR1 and ATP8A1.
For the mutations detected in the Dutch and Pakistani families,
180 and 240 ethnically matched healthy controls were tested,
respectively. For determining the presence of the c.628-9C>A
transversion, exon 3was ampliﬁed and PCR products were puriﬁed
as described for sequencing. Digestion of the PCR products with
BfaI (New England Biolabs) was performed in accordance with
the manufacturer’s protocol, and restriction fragments were
analyzed on 2% agarose gels. Themutation introduces a restriction
site. The c.627þ19A>T transversionwas tested via an ampliﬁcation
refractorymutationsystem(ARMS)approach;primer sequences are
provided in Table S1. Sequence analysis was used to test for the
presence of the additional variants in healthy controls.
Bioinformatic Analysis of Sequence Variants
For prediction of the effect of the c.628-9C>A and c.627þ19A>T
transversions on splicing efﬁciency, we used the following
software tools: NNSPLICE version 0.9, NetGene2, and GeneS-
plicer.18–20 For prediction of exonic splice enhancers (ESEs), the
ESEﬁnder was used.21,22 We employed Polymorphism Phenotyp-
ing (Polyphen) and Sorting Intolerant from Tolerant (SIFT) to
predict the possible pathogenic effect of the p.Arg138Cys substitu-
tion. In addition, we applied Grantham’s chemical-difference
matrix and the Blosum62 and PAM120 matrices.23–25
Experimental Evaluation of Sequence Variants
for Effects on Splicing
Total RNA was isolated from Epstein-Barr-virus-transformed lym-
phoblastoid cells of affected individuals with the NucleoSpin
RNA II Kit (Machery Nagel) in accordance with the manufacturer’s
protocol. Subsequently, cDNA synthesis was performed with
1.5 mg RNA as starting material with the use of the iScript cDNA
Synthesis Kit (Bio-Rad Laboratories),in accordance with the manu-
facturer’s protocol. For evaluation of the effect of the c.628-9C>A
and c.627þ19A>Tmutations on splicing, 2 ml of cDNAwas ampli-
ﬁed via a seminested PCR. For the second PCR, 1 ml of the ﬁrst PCRn Journal of Human Genetics 86, 138–147, February 12, 2010 139
Table 1. GRXCR1 Mutations and Maximum LOD Scores for the DFNB25 Region
Family ID No. of HI Individuals Maximum LOD Score Sequence Variants
No. of Alleles Observed in
Ethnically Matched Chromosomes
W98-053a 3 - c.628-9C>A 0/360
W07-0122a 1 - c.627þ19A>T 0/360
DEM 4003Ab 6 3.42 - -
DEM 4026b 5 1.29 - -
DEM 4045b 2 1.68 - -
DEM 4124Ab 4 2.87 - -
DEM 4145b 3 1.01 - -
DEM 4171b 2 1.20 - -
DEM 4259c 2 1.93 - -
DEM 4265c 4 3.30 c.229C>T (p.Gln77X) 0/480
DEM 4335c 4 1.93 - -
DEM 4349c 2 1.93 c.412C>T (p.Arg138Cys) 0/480
a These families were studied by homozygosity mapping.
b These families were genotyped via a genome scan with ~400 fluorescently labeled short tandem repeat markers.
c These families were genotyped via a linkage panel containing approximately 6000 SNPs.was used with an alternative reverse primer in a total number of
35 PCR cycles. Primer sequences are provided in Table S1. PCR
products were analyzed via agarose gel electrophoresis, puriﬁed,
and sequenced as described above.GRXCR1 Expression Proﬁle
RNA derived from adult heart, prostate, liver, lung, retina, brain,
duodenum, kidney, spleen, and testis as well as from fetal liver
was purchased from Clontech. RNA derived from fetal brain,
colon, kidney, stomach, spleen, and thymus was purchased from
Stratagene. In addition, RNAwas isolated from fetal cochlea, heart,
muscle, and lung as described previously.26 cDNAwas synthesized
as described above and puriﬁed with NucleoSpin Extract II
columns (Macherey-Nagel) in accordance with the manufacturer’s
protocol. For PCR, speciﬁc primers (Table S1) were designed with
Primer3Plus and reference sequence NM_001080476.1. PCRs
were performed with the Applied Biosystem Fast 7900 System in
accordance with the manufacturer’s protocol. The human beta
glucuronidase gene (GUSB [MIM 611499]) was employed as an
internal control. PCR mixtures were prepared with the Power
Syber Green Master Mix (Applied Biosystems) in accordance
with the manufacturer’s protocol. Temperatures and reaction
times for PCR were as follows: 10 min at 95C, followed by 40
cycles of 15 s at 95C and 30 s at 60C. All reactions were per-
formed in duplicate. Relative gene expression levels were deter-
mined with the delta delta Ct method as described previously.27Results
Homozygosity Mapping Conﬁnes the Critical Region
of DFNB25
For the identiﬁcation of genes that cause arNSHI, homozy-
gosity mapping was performed in a large series of 59
familial and 23 isolated arNSHI patients of Dutch origin.
In family W98-053, with three affected siblings, the largest140 The American Journal of Human Genetics 86, 138–147, Februaryoverlapping homozygous region, 3.1 Mb, was located on
chromosome 2q11.1-11.2. The second-largest overlapping
homozygous region, 2.0 Mb, was identiﬁed on chromo-
some 4p13, which was located within the deafness locus
DFNB25, presented on the Hereditary Hearing Loss Home-
page, and for which the causative gene had not yet been
identiﬁed. In the single HI individual of W07-0122, mul-
tiple large homozygous regions were detected. However,
the largest homozygous region (38.6 Mb), located on
4p13-q21.21, partially overlapped with the homozygous
region found in family W98-053. Linkage analysis in fami-
lies of Pakistani origin revealed linkage or an indication of
linkage to the chromosomal region associated with
DFNB25 in ten families (Table 1). The homozygous region
shared by all families contained the ﬁrst exon of the
ATP8A1 gene, the complete GRXCR1 gene, and four addi-
tional uncharacterized expressed sequence tags (ESTs)
(Figure 1). The haplotypes of the shared homozygous
interval differed among the families, suggesting that
different mutations are present (Table S2).
Mutations in GRXCR1 Are Causative of DFNB25
Mutation analysis was performed for exon 1 of ATP8A1
and all exons of GRXCR1 including all exon-intron bound-
aries. No sequence variants were found in the ﬁrst exon of
ATP8A1. However, in both Dutch families and in two of
the Pakistani families, potentially pathogenic variants
were detected in GRXCR1, including intronic variants in
splice sites, a missense mutation, and a nonsense muta-
tion. In family W98-053, a homozygous sequence variant,
c.628-9C>A, was present in the splice acceptor site of exon
3, and in family W07-0122, the variant c.627þ19A>T was
found in the homozygous state in the splice donor site of
exon 2 (Figure 2).12, 2010
Figure 1. Homozygous Regions and Linkage Intervals within DFNB25
Schematic representation of chromosomal region 4p14-q12 showing the homozygous regions in families W98-053 and W07-0122 and
the linkage intervals for families DEM 4265 and DEM 4349. The overlapping region contains the GRXCR1 gene and exon 1 of the
ATP8A1 gene. In addition, four ESTs are localized in the region, which are not further characterized. The Mb positions and chromosome
bands were determined with the UCSC Genome Browser (NCBI build 36.1; hg18 annotation tracks, March 2006).In family DEM 4265, of Pakistani origin, we identiﬁed
a homozygous nonsense mutation, c.229C>T, which
leads to premature protein truncation after residue 76
(p.Gln77X). Furthermore, in family DEM 4349, a homozy-
gous missense mutation, c.412C>T (p.Arg138Cys), was
detected in exon 2. Arg138 is fully conserved in GRXCR1
orthologs (Figure 3B and Figure S4). The p.Arg138CysFigure 2. Mutation Analysis of GRXCR1 in arNSHI Patients
Partial sequences are shown of GRXCR1 from affected members of
acid changes and the surrounding amino acids are indicated above
Reference sequences are NT_006238.10 for the nucleotide sequence
The Americasubstitution introduces a hydrophic residue for a hydro-
philic, positively charged residue and was scored as
‘‘probably damaging’’ for protein function with PolyPhen
and as ‘‘not tolerated’’ by SIFT. Also, the Blosum62 matrix,
the PAM120 matrix, and the Grantham score for this
amino acid change indicate that it is potentially damaging
for protein function.23–25 Analysis of the c.412C>Tthe different families and healthy controls. The predicted amino
the sequence. Mutated nucleotides are marked by an arrowhead.
and NP_001073945.1 for the amino acid sequence.
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Figure 3. Alignment of the GRXCR1
Proteins of Different Species
(A) Overview of the conserved domains in
GRXCR1 as predicted by different software
tools. The GRX-like domain is predicted to
be present by all three programs. However,
the exact positions differ.
(B) An alignment of GRXCR1 orthologs
was made with ClustalW and Jalview,39,40
and part of the GRXCR1 protein is shown.
Abbreviations are as follows: Hs, Homo
sapiens; Pt, Pan troglodytes; Mm, Mus mus-
culus; Rn, Rattus norvegicus; Gg, Gallus
gallus; Dr, Danio rerio. Fully conserved
amino acids are marked in dark gray, and less-conserved amino acids are in lighter colors. Accession numbers of the various protein
sequences are as follows: Hs GRXCR1, NP_001073945.1; Pt LOC461192, XP_517170.2; Mm Grxcr1, NP_001018019.1; Rn Grxcr1,
XP_573590.2; Gg LOC770624, XP_001233963.1; Dr LOC100150769, XP_001919567.1.alteration with the ESEﬁnder showed that a SC35 exonic
splicing enhancer motif is present in the wild-type
sequence but is replaced by a SRp40 recognition motif in
the mutated sequence. This may have an effect on splicing
efﬁciency.
Three bioinformatic tools, Genesplicer, NetGene2, and
NNSPLICE, were used to predict the effect of the mutations
on splicing efﬁciency (Table 2). For the c.628-9C>A
change, a novel splice acceptor site is predicted to replace
the original one. For the c.627þ19A>T variation, a novel
splice donor site is predicted in addition to the original
site. Usage of these novel splice sites would result in a
frameshift and a premature-stop codon; pGly210LeufsX5
and pGly210ValfsX14, respectively. Neither additional
splice donor or acceptor sites nor changes in existing sites
were predicted to result from the other mutations.
All four presumably pathogenic GRXCR1 mutations
cosegregated with hearing impairment in the families (Fig-
ure S3) and were not present in ethnically matched
controls; i.e., 180 Dutch or 240 Pakistani individuals with
normal hearing.
To evaluate the prevalence of GRXCR1 mutations in
arNSHI in The Netherlands, we screened this gene for
mutations in 79 unrelated familial and isolated patients
of Dutch origin. This revealed no putatively pathogenic
variants. However, two SNPs were detected that were not
present in any of the public SNP databases. The c.25G>ATable 2. Overview of the Predicted Splicing Effects of the GRXCR1 Mu
Family Mutation NNsplice NetGene2
W98-053 c.628-9C>Aa original splice acceptor site: 0.94 original splice
novel splice acceptor site: 0.98 novel splice ac
W07-0122 c.627þ19A>Tb original splice donor site: 1.00 original splice
novel splice donor site: 1.00 novel splice do
DEM 4265 c.299C>T no changes no changes
DEM 4349 c.412C>T no changes no changes
a With all splice-prediction programs, the original splice acceptor site is replaced
b With all splice-prediction programs, the original splice donor site is predicted
introduced by the c.627þ19A>T mutation.
142 The American Journal of Human Genetics 86, 138–147, Februaryvariant (p.Glu9Lys; dbSNP ss182258860) was found heter-
ozygously in 12 Dutch index patients and in 14 of 360
Dutch control alleles. This variant was also observed in a
homozygous state in several members of family DEM
4349, including an unaffected parent and unaffected child,
and in 19 of 480 Pakistani control alleles. One additional
alteration, c.272G>T (p.Gly91Val; dbSNP ss182258861),
was found in the heterozygous state in one index patient.
Although this alteration was not present in 180 Dutch
control individuals, it was present in the heterozygous
state and in the homozygous state in 13 of 240 and in 1
of 240 normal-hearing Pakistani controls, respectively.
c.628-9C>A Alters Splicing of GRXCR1
RNAwas isolated from lymphoblastoid cells and cDNAwas
synthesized for affected members of families W98-053 and
W07-0122 for assessment of the effect of the putative
mutations on splicing. In two siblings of family W98-053
(II.2 and II.3), ampliﬁcation of GRXCR1 cDNAwas success-
ful and sequence analysis demonstrated the presence of
seven additional base pairs between exons 2 and 3 leading
to a frameshift and a premature stopcodon, p.Gly210-
LeufsX5 (Figure 4). Ampliﬁcation of GRXCR1 cDNA for
the third affected individual of this family and for the
patient of family W07-0122 was unsuccessful in several
attempts, which is likely a result of the low expression level
of GRXCR1 in lymphoblastoid cells.tations
GeneSplicer ESEfinder
acceptor site: 0.50 original acceptor splice site: 8.58 no changes
ceptor site: 0.28 novel splice acceptor site: 5.73
donor site: 1.00 original splice donor site: 3.08 no changes
nor site: 0.00 novel splice donor site: 5.26
no changes no changes
no changes SC35 motif replaced
by a SRp40 motif
by a novel splice acceptor site as a result of the c.628-9C>A mutation.
with an unchanged score, and a second splice donor site is predicted to be
12, 2010
Figure 4. Splicing Effect of the c.628-9C>A Mutation
Partial sequence of GRXCR1 cDNA from an affected member of
family W98-053 and a healthy control. Additional nucleotides
are present between exons 2 and 3, leading to a frameshift and
a premature-stop codon, p.Gly210LeufsX5.GRXCR1 Is Preferentially Expressed in the Cochlea
The expression ofGRXCR1 relative toGUSBwas studied via
quantitative PCR in human fetal cochlea and compared to
that in ten adult and ten fetal-stage human tissues
(Figure 5). Because this was performed for adult and fetal
tissues in two separate experiments, fetal cochlea was
included in both in order to enable comparison of the
expression levels. In adult tissues, there was relatively
low expression of GRXCR1 in lung, brain, and duodenum,
and a relatively moderate expression was seen in testis. The
expression in fetal cochlea was 5.8–163 times higher than
in the adult tissues that expressGRXCR1. In six of the adult
tissues—heart, prostate, liver, retina, kidney, and spleen—
expression of GRXCR1 was below the detection level.
Furthermore, a low relative GRXCR1 expression was
observed in fetal heart and fetal spleen, but the overall
highest relative expression by far was seen in fetal cochlea.
The expression in fetal cochlea is 15.7 times higher than
that in fetal heart and is over 300 times higher than that
in fetal spleen. In the other fetal tissues, including fetal
muscle, liver, lung, brain, colon, kidney, stomach, and
thymus, expression was below the detection level.
Characteristics of Hearing Loss and Vestibular
Dysfunction Associated with GRXCR1 Mutations
Affected individuals of families W98-053 and W07-0122
exhibited normal development of speech despite the very
early-onset or even congenital nature of the disease. The
HI child in W07-0122 did not pass neonatal hearing
screening, and brainstem-evoked response audiometry
(BERA) at the age of 2.5 mo showed a threshold of 40 dB
at both sides. For family W98-053, BERA was performed
for individuals II.2 and II.4 at the ages of 3.5 mo and 6
mo, respectively, which revealed a threshold of 55–65 dB
for II.4 and no responses for II.2. For individual II.1,
hearing impairment was diagnosed at the age of 19 mo.
In families W98-053 and W07-0122, the hearing loss is
bilateral, symmetric, and sensorineural. Otoacoustic emis-
sions were examined only for the affected subject of family
W07-0122 and were found to be absent. Representative
audiograms of all four HI subjects are presented in Figure 6.
Linear-regression analyses of longitudinal series of
pure-tone audiograms showed signiﬁcant progression ofThe Americahearing loss in the HI members of family W98-053. The
hearing loss progressed from moderate or severe to severe
or profound in this family. The annual threshold deteriora-
tion was in the range of 0.3–3 dB. The HI child of family
W07-0122 is now 4 yrs old and has moderate hearing
loss. Future measurements will reveal whether the hearing
loss in this child is progressive.
All subjects of family W98-053 had normal motor devel-
opment. However, symptoms of vestibular dysfunction
were noticed for individuals II.1 and II.2 around the ages
of 4 and 6 yrs, respectively, and no responses could be
registered upon rotatory stimulation. Normal motor devel-
opment in these patients suggests that the vestibular
dysfunction was not congenital. So far, there were no
symptoms of vestibular dysfunction in the HI individual
of W07-0122, and motor development was normal until
now.
The affected individuals of families DEM 4265 and DEM
4349 did not develop speech, which suggests amore-severe
hearing loss in the critical period as compared to that in
families W98-053 and W07-0122. Representative audio-
grams for affected subjects of the Pakistani families DEM
4265 and DEM 4349 show a pattern similar to those of
HI individuals of family W98-053. The audiograms are
ﬂat, slightly U-shaped, or slightly downsloping, and the
hearing loss is moderate to severe. There is no evidence
for progression of the hearing loss or vestibular dysfunc-
tion in families DEM 4265 and DEM 4349.
On the basis of the current data, we can conclude that
mutations in GRXCR1 cause congenital or early-onset
moderate to severe hearing loss and that the hearing
impairment can progress to profound. Also, the hearing
loss can be accompanied by vestibular dysfunction with
a childhood onset.Discussion
Here, we describe the DFNB25 locus and present evidence
that mutations in GRXCR1 underlie arNSHI associated
with this locus, which was indicated previously at the
Hereditary Hearing Loss Homepage. In four families, we
identiﬁed three putatively truncating mutations and a
missense mutation. The latter is not associated with a
less-severe hearing loss as compared to the truncating
mutations. No GRCXR1 mutations were detected in eight
families in this study with suggestive linkage to the
DFNB25 locus, and the original DFNB25 family did not
reveal any GRXCR1 mutations. Also, in the latter family
the LOD score did not reach statistical signiﬁcance (Ri-
chard Smith, personal communication). These families
may have mutations in regions of the gene that have not
been analyzed; the regulatory and intronic regions. Alter-
natively, the disease in these families may be caused by
defects in a second deafness gene in the region or by
a gene in a different locus, given that a statistically signif-
icant LOD score was reached for only one of these families.n Journal of Human Genetics 86, 138–147, February 12, 2010 143
Figure 5. GRXCR1 Expression Profile
Relative GRXCR1 mRNA expression deter-
mined by quantitative PCR in adult (A)
and fetal (B) tissues. The relative expres-
sion values were determined with the delta
delta Ct method. There is a highly prefer-
ential expression in fetal cochlea.GRXCR1 (glutaredoxin, cysteine rich 1) is a 290-residue
protein with a cystein-rich C-terminal region and a pre-
dicted GRX domain. The p.R138C substitution is at the
N terminus of the GRX domain or just outside, depending
on the prediction tool (Figure 3A) and therefore may also
affect its function. The nonsense mutation p.Gln77X trun-
cates the protein at the N terminus of the predicted GRX
domain. Aberrant splicing due to both splice-site muta-
tions may result in the absence of part of this domain
unless nonsense-mediated decay (NMD) occurs. NMD will
lead to absence or strongly reduced amounts of a truncated
protein, which may well be unstable or mislocalized. NMD
eliminates mRNAs that contain premature-translation
termination codons.28 In mammalian cells, a termination
codon is recognized as premature if it is located more than
50–54 nt 50 to the ﬁnal exon-exon junction.29 When one
applies this 50–54 nt boundary rule, the nonsense muta-
tion and one of the splice-site mutations, c.628-9C>A,
may result in NMD of the GRXCR1 mRNA. Whether144 The American Journal of Human Genetics 86, 138–147, February 12, 2010NMD indeed occurs for these muta-
tions has not been investigated.
The GRX domain is the catalytic
domain in glutaredoxins, enzymes
that utilize the reducing power of
glutathione to catalyze disulﬁde
reductions in the presence of NADPH
and glutathione reductase.6,30 As
such, glutaredoxins are involved in
the reversible S-glutathionylation of
proteins and thereby in the modula-
tion of activity and/or localization of
these proteins.6 Actin is one of the
well-known examples of S-glutathio-
nylated proteins, and the modiﬁca-
tion is likely to decrease the rate of
polymerization and affect localiza-
tion.6,31
A roleof glutaredoxins, andpossibly
GRXCR1, in actin organization is
interesting in light of the phenotype
of the pi mouse mutant. A defective
mouse ortholog of GRXCR1, Grxcr1,
was reported to underlie the deafness
and circling behavior of this pimouse.
(Hunker, K.L. et al., 2005, Assoc. Res.
Otolaryngol., abstract; Hunker, K.L.
et al., 2006, Assoc. Res. Otolaryngol.,
abstract; Kohrman, D.C. et al., 2008,Assoc. Res. Otolaryngol., abstract). In the homozygous pi
mutant mice, stereocilia arise normally but their matura-
tion is altered, resulting in somewhat disorganized and
abnormally short and thin sterecilia of cochlear and vestib-
ular hair cells.8,9 In addition, an actin-rich bundle called
cytocaud is present in inner hair cells and type I vestibular
hair cells. The cytocaud spans thewhole cell, from the cutic-
ular plate to the basal part, and extends further, toward
the basement membrane.8 Cytocauds are also described in
hair cells of shaker 2 mice with a mutated Myo15a and in
the Tasmanian devil (tde) and tg-370 transgenic lines.8,9,32
Both the tde and tg-370 strains have inner-ear dysfunction
comparable to that in the pi strain, and they are described
to be allelic to pi on the basis of complementation tests.
Defects in Grxcr1 have so far not been described for these
strains.
The abnormally short and thin stereocilia in combina-
tion with the formation of cytocauds due to defects in
Grxcr1 indeed indicate a role in the regulation of actin
Figure 6. Clinical Characterization of DFNB25 Families
(A–D) Representative audiograms of the right ear of affected indi-
viduals of families W98-053 and W07-0122 at different ages.
Dashed lines indicate free-ﬁeld measurements.
(E and F) Representative audiograms of affected individuals of
families DEM 4265 and DEM 4349, obtained at the ages of 19
and 26 yrs, respectively. Circles and crosses represent the right
and left ear, respectively.polymerization or organization in hair cells. This is sup-
ported by the observations of Hunker et al. (Hunker KL
et al., 2006, Assoc. Res. Otolaryngol., abstract) of Grxcr1’s
localization to stereocilia of hair cells and microvilli of
nonsensory cells when expressed in cochlear explants.
Association of Grxcr1 with actin-ﬁlament-rich structures
is also seen upon expression in cultured ﬁbroblasts and
other epithelial cells. (Hunker KL et al., 2006, Assoc. Res.
Otolaryngol., abstract).
Our results indicate that defects in GRXCR1 can be asso-
ciated with both progressive and stable hearing loss. So far,
progression of arNSHI has been associated only with muta-
tions in a few other genes; namely,MYO3A (MIM 606808),
TMPRSS3 (MIM 605511), PJVK (MIM 610219), and
LOXHD1(MIM 613072)33–37 and, recently, with a recessive
mutation in TMC1 (MIM 606706) (C.C., P.H., H.K., and
J.O., unpublished data). In patients with mutations in
these genes, the onset of progressive hearing loss is during
childhood, whereas in family W98-053, it is congenital orThe Americahas an onset in early infancy. An association with both
progressive and stable hearing impairment has previously
been reported for TMPRSS334,35 and is also known for
TMC1 (C.C., P.H., H.K., and J.O., unpublished data).38
In conclusion, defects inGRXCR1/Grxcr1 in humans and
mice lead to early-onset hearing loss and can be associated
with vestibular dysfunction. The latter is so far diagnosed
in one of the families. Residual hearing has been described
for the pi strain,9 and in families DEM4265 andDEM4349,
residual hearing is present. This is also the case in family
W98-053, although progression in this family may lead
to complete deafness.Supplemental Data
Supplemental Data include four ﬁgures and two tables and can be
found with this article online at http://www.ajhg.org.Acknowledgments
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